Definitive Contract HT942523C0083

Award Date 9/25/23
Potential Completion Date 9/24/27
Potential Value $6.4M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Milwaukee, WI 53226, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
19
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This $6,403,731.00 definitive contract was awarded by the Defense Health Agency (DHA) to the Medical College of Wisconsin, Inc. (MCW), a private, non-profit university located in Milwaukee, Wisconsin. The contract is for a prospective study titled "POINT-MTBI: Prospective Study of Point-of-Care Blood-Based Biomarkers in Acute Military, Civilian, and Sport-Related Mild Traumatic Brain Injury (MTBI)". The contract has an ultimate completion date of September 24, 2027 and was awarded on September 25, 2023. This contract was not set aside for small businesses.

MCW is a major national research center that conducts biomedical research, medical education, and healthcare services. They have expertise in various medical and scientific disciplines, including neuroscience, and have participated in numerous federally-funded studies and clinical trials for agencies like the Department of Veterans Affairs and DHA. This contract aligns with DHA's mission to advance medical knowledge and improve patient care, particularly in the area of traumatic brain injury.

Generated 8/28/24, 11:08 AM